<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Canada Finance: VRX.TO News</title><copyright>Copyright (c) 2013 Yahoo! Inc. All rights reserved.</copyright><link>http://ca.finance.yahoo.com/q/h?s=vrx.to</link><description>Latest Financial News for VALEANT PHARMACEUTICALS INTL IN</description><language>en-CA</language><lastBuildDate>Fri, 17 May 2013 17:12:44 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Canada Finance: VRX.TO News</title><link>http://ca.finance.yahoo.com/q/h?s=vrx.to</link><width>144</width><height>45</height></image><item><title>Warner Chilcott buy may be Actavis&apos; best takeover defense</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12l07lolp/*http://www.reuters.com/article/2013/05/17/us-dealtalk-actavis-idUSBRE94G0N120130517?feedType=RSS&amp;feedName=innovationNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/1487811378</guid><pubDate>Fri, 17 May 2013 17:12:44 GMT</pubDate></item><item><title>DEALTALK: Warner Chilcott buy may be Actavis&apos; best takeover defense</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12i35tq0q/*http://www.reuters.com/article/2013/05/17/dealtalk-actavis-idUSL2N0DX2EP20130517?feedType=RSS&amp;feedName=financialsSector&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/3457347943</guid><pubDate>Fri, 17 May 2013 16:57:24 GMT</pubDate></item><item><title>Drugmaker Actavis&apos; shares up</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/drugmaker-actavis-shares-133937161.html</link><description></description><guid isPermaLink="false">yahoo_finance/2295626110</guid><pubDate>Thu, 16 May 2013 13:39:37 GMT</pubDate></item><item><title>Novartis says has no intention of buying Actavis</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12lq2b3f5/*http://www.reuters.com/article/2013/05/16/us-actavis-novartis-idUSBRE94F0KH20130516?feedType=RSS&amp;feedName=innovationNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/374874498</guid><pubDate>Thu, 16 May 2013 12:58:14 GMT</pubDate></item><item><title>Ahead of the Bell: Drugmaker Actavis&apos; shares up</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ahead-bell-drugmaker-actavis-shares-125655134.html</link><description></description><guid isPermaLink="false">yahoo_finance/3994217142</guid><pubDate>Thu, 16 May 2013 12:56:55 GMT</pubDate></item><item><title>What WSJ Canada Is Reading Thursday</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12n3vlo02/*http://blogs.wsj.com/canadarealtime/2013/05/16/what-wsj-canada-is-reading-thursday-7/?mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/3857052179</guid><pubDate>Thu, 16 May 2013 12:17:51 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant&apos;s Board of Directors</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-resignation-dr-001600308.html</link><description>[CNW Group] - Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant&apos;s Board of Directors</description><guid isPermaLink="false">yahoo_finance/2027468443</guid><pubDate>Thu, 16 May 2013 00:16:00 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant&apos;s Board of Directors</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://ca.finance.yahoo.com/news/valeant-pharmaceuticals-announces-resignation-dr-001600131.html</link><description>[CNW Group] - LAVAL, Quebec , May 15, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that Dr. Laurence Paul has resigned from Valeant&apos;s Board of Directors due to expanded business, ...</description><guid isPermaLink="false">yahoo_finance/2325356149</guid><pubDate>Thu, 16 May 2013 00:16:00 GMT</pubDate></item><item><title>Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant&apos;s Board of Directors</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-resignation-dr-001500812.html</link><description>[PR Newswire] - LAVAL, Quebec, May 15, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that Dr. Laurence Paul has resigned from Valeant&apos;s Board of Directors due to expanded ...</description><guid isPermaLink="false">yahoo_finance/2420347610</guid><pubDate>Thu, 16 May 2013 00:15:00 GMT</pubDate></item><item><title>[$$] Drug Firms Stalk Actavis</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12g9vt1li/*http://online.wsj.com/article/SB10001424127887323398204578485494024877354.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/1356608424</guid><pubDate>Wed, 15 May 2013 23:17:07 GMT</pubDate></item><item><title>Actavis rejected $15 billion offer from Mylan: source</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/actavis-rejected-15-billion-offer-232313086.html</link><description></description><guid isPermaLink="false">yahoo_finance/1829138687</guid><pubDate>Tue, 14 May 2013 23:23:13 GMT</pubDate></item><item><title>Actavis rejected $15 billion offer from Mylan - source</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12j4a5l4d/*http://www.reuters.com/article/2013/05/14/actavis-mylan-bid-idUSL2N0DV3YN20130514?feedType=RSS&amp;feedName=rbssHealthcareNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/4193143916</guid><pubDate>Tue, 14 May 2013 23:13:04 GMT</pubDate></item><item><title>Actavis Said to Have Spurned $15 Billion Offer From Mylan</title><link>http://us.rd.yahoo.com/finance/external/bloomberg/rss/SIG=13br57dmu/*http://www.bloomberg.com/news/2013-05-14/actavis-said-to-have-spurned-15-billion-offer-from-mylan-1-.html?cmpid=yhoo</link><description></description><guid isPermaLink="false">yahoo_finance/2511892613</guid><pubDate>Tue, 14 May 2013 17:38:38 GMT</pubDate></item><item><title>Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/valeant-pharmaceuticals-webcast-2013-annual-210100825.html</link><description>[CNW Group] - Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders</description><guid isPermaLink="false">yahoo_finance/1189970103</guid><pubDate>Mon, 13 May 2013 21:01:00 GMT</pubDate></item><item><title>Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://ca.finance.yahoo.com/news/valeant-pharmaceuticals-webcast-2013-annual-210100166.html</link><description>[CNW Group] - LAVAL, Quebec , May 13, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company&apos;s annual meeting of shareholders. ...</description><guid isPermaLink="false">yahoo_finance/3109738577</guid><pubDate>Mon, 13 May 2013 21:01:00 GMT</pubDate></item><item><title>Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/valeant-pharmaceuticals-webcast-2013-annual-210000007.html</link><description>[PR Newswire] - LAVAL, Quebec, May 13, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company&apos;s annual meeting of shareholders. ...</description><guid isPermaLink="false">yahoo_finance/3587980434</guid><pubDate>Mon, 13 May 2013 21:00:00 GMT</pubDate></item><item><title>Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/valeant-pharmaceuticals-international-inc-announces-210200040.html</link><description>[CNW Group] - Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal</description><guid isPermaLink="false">yahoo_finance/2610398131</guid><pubDate>Fri, 10 May 2013 21:02:00 GMT</pubDate></item><item><title>Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://ca.finance.yahoo.com/news/valeant-pharmaceuticals-international-inc-announces-210200513.html</link><description>[CNW Group] - LAVAL, Quebec , May 10, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has provided additional information related to the proposal to continue ...</description><guid isPermaLink="false">yahoo_finance/1412706128</guid><pubDate>Fri, 10 May 2013 21:02:00 GMT</pubDate></item><item><title>[$$] Actavis in Early Talks About Acquisition of Warner Chilcott</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ghaqeag/*http://online.wsj.com/article/SB10001424127887324244304578475173287822996.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/3589041098</guid><pubDate>Fri, 10 May 2013 21:01:08 GMT</pubDate></item><item><title>Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/valeant-pharmaceuticals-international-inc-announces-210000296.html</link><description>[PR Newswire] - LAVAL, Quebec, May 10, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has provided additional information related to the proposal to continue ...</description><guid isPermaLink="false">yahoo_finance/3807611948</guid><pubDate>Fri, 10 May 2013 21:00:00 GMT</pubDate></item></channel></rss>